In June 4th, the State Planning Commission issued the "notice on the work of the procurement of low-cost drugs commonly used, the notice is divided into six parts, the following interpretation of the interpretation of the analysis, for the industry reference only.
Clarify the fuzzy point, giving the public hospital bargaining power
Niu Zhengqian said, in general, "notice" highlights a lot, with a breakthrough, to clarify the low cost of drug procurement management, many of the fuzzy point. In particular, the use of low-cost drugs in public hospitals, the hospital directly linked to the network through the production of transactions, in a timely manner." Means in low-cost drugs, the public hospitals in the primary medical institutions have a certain independent bargaining power of procurement, is not a small progress in drug pricing reform.
But I also worry, current due to the grassroots medical institutions drug purchase cheap right, still be health authorities firmly in control, which means that currently in the implementation of the basic drug system have been exposed to drug delivery cycle is long, tedious link, compensation is difficult to place, village health room drug shortages caused by tender, will still exist.
Three "bright spot" analysis
State Drug holding senior industry researcher Gan Rongfu believes that the "notice" issued in a very timely manner, is a very good document. There are three main highlights:
1, in the development and Reform Commission issued a more than a month after the low price policy, Wei Planning Commission to respond to the policy convergence and coordination of the Department is in place, which is expected to ensure the smooth implementation of low-cost drugs;
2, "government basic medical and health care institutions to use low-cost drugs commonly used, by provincial drug procurement agencies summary of basic medical and health institutions and drug procurement requirements, the implementation of centralized purchasing, commissioned by the grassroots signed a purchase and sale contract, centralized payment. The use of low-cost drugs in public hospitals, the hospital directly linked to the network through the production of transactions, in a timely manner. The hospital should give priority to the purchase of drugs through the new version of GMP certification and production enterprises, and with the production enterprise or its authorized business enterprise signed a purchase and sale contract, clear payment procedures and time." Qualitative changes in the way of purchasing and basic medicine, to increase the degree of freedom of the hospital and enterprise market.
3, can be seen from this notice, Wei Planning Commission to encourage the use of cheap drugs in hospitals, clear centralized bulk purchase".
Deputy Secretary General of association of medical supplies, China long blue lie founder Wei Shaofeng carries out the following interpretation of the "notice":
To put forward to join the procurement policy
Many also indecisive, or did not disclose the connection scheme. Notice issued after it became necessary to join the bidding and procurement, by the provincial bidding office to implement. Convergence of the object, including the basis of tender and non - tender tender.
At the same time there is not clear how many: how convergence, the provinces themselves set; convergence of the timetable did not mention the free arrangement of the provinces.
Business strategy: always pay attention to the provincial bidding, through a variety of ways to find out how to connect, assess their own advantages and disadvantages, as soon as possible to deal with the strategy, to do the things that are prepared.
The purchasing power concentrated together
Notice that the government basic medical and health care institutions to use low-cost drugs commonly used, by provincial drug procurement agencies summary of basic medical and health institutions and drug procurement requirements, centralized purchasing, commissioned by the grassroots signed a purchase and sale contract, centralized payment.
It can be seen that the grassroots medical institutions to purchase low-cost drugs is no bargaining power, each unit only reported demand, the province's centralized procurement, once into the low-cost drugs, number of the grassroots purchase will be great, enterprises and the central purchasing platform deal, making a good price, good distribution can be, but also very easy, but basic maintenance and the amount is still a topic.
The use of low-cost drugs commonly used in public hospitals, the hospital directly linked to the network through the production of a transaction, in a timely manner, the hospital has a bargaining space, to a certain extent, to the tender.
Three noteworthy control measures
1, the price control. After the introduction of some time ago cheap drug list, many enterprises plotting price, but the notice of proposed, improve procurement, distribution concentration, avoid undue volatility drug prices. Fluctuations in the up and down, according to the tender thinking around, of course, is not a problem, but here refers to fluctuations, mainly refers to prices, want to took the opportunity to rise in price, youzhaodian abuse.
2, the supply capacity, distribution of the arrival rate and the credibility of the control. The implementation of statistical analysis, dynamic regulation, the new version of GMP, GSP are a plus.
3, the prevention and control of corruption. There have been a number of provinces, the introduction of the medical and public health system in the "black list" implementation plan, purchasing cheap drugs is also included in the scope of regulation of the system. Planning requirements for the strict implementation of repaying the credit records and market system, the establishment of supervision and punishment mechanism, resist and oppose commercial bribery, corrected pharmaceutical sales field unhealthy.
Part of non - base drugs in the implementation of the policy
Notification requirements, to apply to basic medical and health institutions of low-cost drugs commonly used in non essential drugs, by the provincial health plan administrative departments in accordance with the policy of the basic drug system, the provisions of the primary drug specific requirements.
That is, as long as the low drug into the catalog, and sales at the grassroots level, can enjoy the policy treatment of non base drugs, so that can be promoted"